Regression of glomerular injury by losartan in experimental diabetic nephropathy

Kidney International

Volumn 75, Issue 1, 2009, Pages 72-79

  Teles, Flávio ^a   Machado, Flávia G ^a   Ventura, Bianca H ^a   Malheiros, Denise M A C ^a   Fujihara, Clarice K ^a   Silva, Luís F F ^a   Zatz, Roberto ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratorio de Fisiopatologia Renal   (Brazil)

Author keywords

Angiotensin II; Chronic kidney disease; Glomerulosclerosis

Indexed keywords

INSULIN; LOSARTAN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; MALE; MORPHOMETRICS; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CELL PROLIFERATION; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERGLYCEMIA; INSULIN; KIDNEY GLOMERULUS; LOSARTAN; MALE; MESANGIAL CELLS; RATS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 58049206764     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.528     Document Type: Article

References (40)

1. Adamczak M, Gross ML, Krtil J et al. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003; 14: 2833-2842.
2. Boffa JJ, Lu Y, Placier S et al. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 2003; 14: 1132-1144.
3. Fioretto P, Steffes MW, Sutherland DE et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
4. Ma LJ, Nakamura S, Aldigier JC et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005; 16: 966-976.
5. Remuzzi A, Gagliardini E, Donadoni C et al. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 2002; 62: 885-894.
6. Takahashi H, Ichihara A, Kaneshiro Y et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 2007; 18: 2054-2061.
7. Perkins BA, Ficociello LH, Ostrander BE et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007; 18: 1353-1361.
8. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases - insights from animal models. Kidney Int 2005; 67: 404-419.
9. Yu C, Gong R, Rifai A et al. Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. J Am Soc Nephrol 2007; 18: 750-759.
10. Aranda P, Segura J, Ruilope LM et al. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. Am J Kidney Dis 2005; 46: 1074-1079.
11. Rossing K, Schjoedt KJ, Jensen BR et al. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005; 68: 1190-1198.
12. Pisoni R, Ruggenenti P, Sangalli F et al. Effect of high dose ramipril with or without indomethacin on glomerular selectivity. Kidney Int 2002; 62: 1010-1019.
13. Fujihara CK, Velho M, Malheiros DMAC et al. An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 2005; 67: 1913-1924.
14. Zatz R, Dunn BR, Meyer TW et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-1930.
15. Fujihara CK, Padilha RM, Zatz R. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy. Diabetes 1992; 41: 286-293.
16. Utimura R, Fujihara CK, Mattar AL et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003; 63: 209-216.
17. Furuta T, Saito T, Ootaka T et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-485.
18. Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98: 1063-1068.
19. Schjoedt KJ, Rossing K, Juhl TR et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int 2005; 68: 2829-2836.
20. Anderson S, Rennke HG, Garcia DL et al. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989; 36: 526-536.
21. Yoo TH, Li JJ, Kim JJ et al. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int 2007; 71: 1019-1027.
22. Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65: 30-39.
23. Mezzano S, Droguett A, Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003; 86: S64-S70.
24. Vaziri ND, Bai Y, Ni Z et al. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007; 323: 85-93.
25. Marinides GN, Groggel GC, Cohen AH et al. Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 1990; 37: 749-757.
26. Ikoma M, Kawamura T, Kakinuma Y et al. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991; 40: 195-202.
27. Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 1998; 6: 57-66.
28. Harris RC, Haralson MA, Badr KF. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics, and metabolic activity. Lab Invest 1992; 66: 548-554.
29. Kawata Y, Mizukami Y, Fujii Z et al. Applied pressure enhances cell proliferation through mitogen-activated protein kinase activation in mesangial cells. J Biol Chem 1998; 273: 16905-16912.
30. Riser BL, Cortes P, Heilig C et al. Cyclic stretching force selectively upregulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol 1996; 148: 1915-1923.
31. Riser BL, Cortes P, Zhao X et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90: 1932-1943.
32. McLennan SV, Kelly DJ, Cox AJ et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275.
33. Ma LJ, Nakamura S, Whitsitt JS et al. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 2000; 58: 2425-2436.
34. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007; 27: 195-207.
35. White KE, Bilous RW. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 2004; 19: 1437-1440.
36. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999; 42: 1341-1344.
37. Parving HH, Lehnert H, Brochner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
38. Fujihara CK, Malheiros DMAC, Zatz R et al. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 1998; 54: 1510-1519.
39. Goncalves AR, Fujihara CK, Mattar AL et al. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol Renal Physiol 2004; 286: F945-F954.
40. Jepsen FL, Mortensen PB. Interstitial fibrosis of the renal cortex in minimal change lesion and its correlation with renal function. A quantitative study. Virchows Arch A Pathol Anat Histol 1979; 383: 265-270.